rss
J Med Ethics 2008;34:849-851 doi:10.1136/jme.2008.024786
  • 10 years of stem cells

The significance of induced pluripotent stem cells for basic research and clinical therapy

  1. J R Meyer
  1. Dr John R Meyer, Prelature of Opus Dei, 765 14th Avenue, San Francisco, CA 94118, USA; jrmeyer{at}prkvw.com
  • Received 7 February 2008
  • Revised 7 May 2008
  • Accepted 9 May 2008

Abstract

It is argued that the use of induced pluripotent stem cells for regenerative therapy may soon be ethically practicable and could sidestep the various objections pertaining to other types of stem cell (human embryonic stem cells, and stem cells obtained by altered nuclear transfer or somatic cell nuclear transfer).

Footnotes

  • Funding: None declared.

  • Competing interests: None.

This Article

  1. Abstract
  2. Full text
  3. PDF

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.